127 related articles for article (PubMed ID: 14101198)
1. IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. II. CORRELATION OF IN VITRO INHIBITION OF DEHYDROGENASE AND GROWTH WITH IN VIVO INHIBITION OF EHRLICH ASCITES TUMOR.
DIPAOLO JA
Proc Soc Exp Biol Med; 1963 Nov; 114():384-7. PubMed ID: 14101198
[No Abstract] [Full Text] [Related]
2. IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. 3. PRELIMINARY STUDIES OF SPONTANEOUS MAMMARY TUMORS IN MICE.
DIPAOLO JA
Cancer Chemother Rep; 1965 Feb; 44():19-24. PubMed ID: 14294807
[No Abstract] [Full Text] [Related]
3. INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
DOWD JE; DIPAOLO JA; WATNE AL
Acta Unio Int Contra Cancrum; 1964; 20():279-83. PubMed ID: 14155995
[No Abstract] [Full Text] [Related]
4. DRUGS OF CURRENT USE FOR THE TREATMENT OF CANCER AND ALLIED DISEASES.
GOLDENBERG DM
Dis Chest; 1963 Dec; 51():191-208. PubMed ID: 14102116
[No Abstract] [Full Text] [Related]
5. STUDIES ON ANTIBODY PRODUCTION. XII. INHIBITION OF PRIMING BY DRUGS.
BUTLER WT; COONS AH
J Exp Med; 1964 Dec; 120(6):1051-60. PubMed ID: 14238924
[TBL] [Abstract][Full Text] [Related]
6. THE ADVERSE EFFECTS OF CANCER CHEMOTHERAPY.
KONDO T
Acta Unio Int Contra Cancrum; 1964; 20():194-8. PubMed ID: 14151882
[No Abstract] [Full Text] [Related]
7. IN VITRO CULTURE OF YOSHIDA SARCOMA CELLS: METHODS FOR DETERMINING ACQUIRED RESISTANCE TO DRUGS.
SAKURAI Y
Natl Cancer Inst Monogr; 1964 Dec; 16():207-39. PubMed ID: 14235655
[No Abstract] [Full Text] [Related]
8. Influences of anticancer agents on the activities of liver catalase, uricase, and xanthine oxidase in normal and tumor-bearing mice.
HANO K; IWATA H; AKASHI A
Gan; 1963 Mar; 54():47-58. PubMed ID: 13952572
[No Abstract] [Full Text] [Related]
9. CANCER CHEMOTHERAPY.
EISMAN SG; RICHARDSON FM
Med Sci; 1964 Mar; 15():63-72. PubMed ID: 14143132
[No Abstract] [Full Text] [Related]
10. EFFECTS OF CHEMICAL TREATMENT IN VITRO OF NELSON MOUSE ASCITES TUMOR CELLS ON THEIR TRANSPLANTABILITY AND ON SOME INDICES OF GLUCOSE METABOLISM.
TARNOWSKI G; KULKA P; BATES L; SAFIER S; SATTERWHITE H; SOLNEY E
Cancer Res; 1963 Oct; 23():1878-91. PubMed ID: 14073550
[No Abstract] [Full Text] [Related]
11. Cancer chemotherapy by intra-arterial infusion.
SCANLON EF; NORA PF; TARKINGTON JA; MEYER NI
Surg Clin North Am; 1963 Feb; 43():31-8. PubMed ID: 13976506
[No Abstract] [Full Text] [Related]
12. [Studies on the pharmacological characterization of a permanent in vitro growing strain of Ehrlich ascites tumor cells].
Schmid I; Karzel K
Arzneimittelforschung; 1968 Dec; 18(12):1498-500. PubMed ID: 4976453
[No Abstract] [Full Text] [Related]
13. Chemotherapy of malignant disease. I. Solid tumours.
REEVE TS
Med J Aust; 1962 Dec; 49(2)():867-70. PubMed ID: 13973605
[No Abstract] [Full Text] [Related]
14. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
RUTMAN RJ
Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
[No Abstract] [Full Text] [Related]
15. Chemotherapy studies in an animal tumor spectrum. II. Sensitivity of tumors to fourteen antitumor chemicals.
Tarnowski GS; Schmid FA; Cappuccino JG; Stock CC
Cancer Res; 1966 Mar; 26(3 Pt 2):181-206. PubMed ID: 4223040
[No Abstract] [Full Text] [Related]
16. OBSERVATIONS ON THE USE OF CANCER CHEMOTHERAPEUTIC AGENTS IN PATIENTS WITH MYCOSIS FUNGOIDES.
WRIGHT JC; LYONS MM; WALKER DG; GOLOMB FM; GUMPORT SL; MEDREK TJ
Cancer; 1964 Aug; 17():1045-62. PubMed ID: 14202592
[No Abstract] [Full Text] [Related]
17. CURRENT STATUS OF CHEMOTHERAPY OF CANCER.
KREMENTZ ET; KOKAME GM; IGLESIAS F
Postgrad Med; 1964 Apr; 35():384-94. PubMed ID: 14131637
[No Abstract] [Full Text] [Related]
18. A SIMPLE QUANTITATIVE METHOD FOR THE INVESTIGATION OF THE INHIBITING ACTION OF CYTOSTATICS ON SUCCINATE DEHYDROGENASE.
DOMBRADI GA
Enzymologia; 1964 Feb; 26():321-8. PubMed ID: 14117127
[No Abstract] [Full Text] [Related]
19. DRUGS USED WITH RADIATION IN THE TREATMENT OF CANCER.
HODNETT EM
Cancer Chemother Rep; 1963 Oct; 32():55-65. PubMed ID: 14088836
[No Abstract] [Full Text] [Related]
20. [PRESENT STATE OF ANTINEOPLASTIC CHEMOTHERAPY FROM THE PHARMACOLOGIC POINT OF VIEW].
NANETTI L; VALLINI R
Minerva Med; 1963 Nov; 54():3353-5. PubMed ID: 14126380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
